However, when assessing how these results impact the response to anti-PD-1 treatments, administering a PD-1 antibody did not affect tumor growth or the survival of mice injected with Pbrm1-knockout Renca cells (Liu et al., 2020). This evidence concerns the gene PBRM1 and neoplasm.